(Q36512761)

14 August 2017

Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes (English)

1 reference

14 August 2017

hepatocellular carcinoma

1 reference

13

Timothy M Pawlik

1 reference

14 August 2017

Peter J Kneuertz

1

1 reference

14 August 2017

Aram Demirjian

2

1 reference

14 August 2017

Amin Firoozmand

3

1 reference

14 August 2017

Celia Corona-Villalobos

4

1 reference

14 August 2017

Nikhil Bhagat

5

1 reference

14 August 2017

Joseph Herman

6

1 reference

14 August 2017

Andrew Cameron

7

1 reference

14 August 2017

Ahmet Gurakar

8

1 reference

14 August 2017

David Cosgrove

9

1 reference

14 August 2017

Michael A Choti

10

1 reference

14 August 2017

Jean-Francois H Geschwind

11

1 reference

14 August 2017

Ihab R Kamel

12

1 reference

14 August 2017

3 April 2012

1 reference

Annals of Surgical Oncology

14 August 2017

1 reference

14 August 2017

19

1 reference

14 August 2017

9

1 reference

14 August 2017

2897-2907

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-012-2336-0

14 August 2017

0 references

cites work

Infiltrating hepatocellular carcinoma: seeing the tree through the forest

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Loco-regional treatment of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Management of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

The epidemiology and prevention of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3538368

Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma

21 September 2018

1 reference

12 December 2020

A clinical and pathological study of diffuse type hepatocellular carcinoma

1 reference

12 December 2020

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

1 reference

12 December 2020

Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors

1 reference

12 December 2020

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

12 December 2020

Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma

1 reference

12 December 2020

Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma

1 reference

12 December 2020

Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments

1 reference

12 December 2020

Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI

1 reference

12 December 2020

Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis

1 reference

12 December 2020

10.1245/S10434-012-2336-0

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference